StofferSS. Substitution of levothyroxine products (letter). JAMA1979; 241: 1229.
2.
StofferSSSzpunarWE. Potency of brand name and generic levothyroxine products. JAMA1980; 244: 1704–5.
3.
Rees-JonesRWRollaARLarsenPR. Hormonal content of thyroid replacement preparations. JAMA1980; 243: 549–50.
4.
JacobsonJMRamos-GabatinAYoungRL. Nonequality of brand name thyroxine preparations (letter). JAMA1980; 243: 733.
5.
Ramos-GabatinAJacobsonJMYoungRL. In vivo comparison of levothyroxine preparation. JAMA1982; 247: 203–5.
6.
SwainCTSurksMLLondonM. Oral thyroxine: Variation in biologic action and tablet content. Ann Intern Med1984; 100: 641–5.
7.
StofferSSSzpunarWE. Potency of levothyroxine products. JAMA1984; 251: 635–6.
8.
HennesseyJVBurmanKDWartofskyL. The equivalency of two L-thyroxine preparations. Ann Intern Med1985; 102: 770–3.
9.
BurmanKDBongiovanniRGarisRK. Measurement of serum T4 concentration by high performance liquid chromatography. J Clin Endocrinol Metab1981; 53: 909–12.
10.
HansenKB. Equivalence of thyroid preparations (letter). JAMA1980; 244: 1095.
11.
IngbarJCBravermanLEIngbarSH. Equivalence of thyroid preparations (letter). JAMA1980; 244: 1095.
12.
Potency of oral thyroxine preparations. Med Lett Drugs Ther1984; 26: 41.
13.
MaxonHRRitschelWAVolleCP. Pilot study on the absolute and relative bioavailability of Synthroid and Levothroid, two brands of sodium levothyroxine. Int J Clin Pharm Toxicol1983; 21: 379–82.
